Join us for a Southeast Regional Educational Meeting
by conference call!
GUEST SPEAKER
John J. Bissler MD
(Pediatric Nephrologist / Kidney Specialist)
TOPIC
Dr. Bissler addresses recent discoveries made in research, what that means to
individuals living with TSC and how it translates into clinical trials.
WHEN?
Tuesday, March 31, 2009
7:00 p.m. CST
8:00 p.m. EST
WHERE?
Please dial 1-866-613-5223
Enter the pass code 9083528 followed by the # sign
Please RSVP to Amy Hobbs
by March 1, 2009
Phone: (615)665-3397 or E-mail: amyghobbs@aol.com
Please RSVP by sending in any questions you may have for Dr. Bissler to Amy. She will compile a list of
all questions and we will be forwarding those to Dr Bissler so he may customize his presentation. This
will enable us to address as many questions as possible without taking up valuable phone time with a
larger crowd. When you have reserved your spot, you will receive a copy of the presentation in late
March.
John J. Bissler MD
Clark D. West Chair of Nephrology Director
Nephrology Fellowship Training Program Associate
Program Director for Research and Academic Careers
John J. Bissler, M.D. is a graduate (AOA) of the Northeastern Ohio Universities College of Medicine
after he earned his B.S. degree (Phi Bata Kappa, Magna Cum Laude) at Kent State University. After a
three-year pediatric residency and chief residency at Akron Children’s Hospital, Dr. Bissler came to
Cincinnati Children’s in 1988 for a fellowship in nephrology and in basic science. In 1991, he was
awarded a William Cooper Procter pediatric research scholarship for two years. Now in his 18th year in
the Division of Nephrology and Hypertension, he is an Associate Professor of Pediatrics and of Cell
Biology as well as a clinical attending physician. In 2004, Dr. Bissler became the first recipient of the
Clark D. West Endowed Chair of Pediatric Nephrology.
Dr. Bissler treats patients with polycystic kidney disease and renal angiomyolipomas. After the brain, the
kidney is the organ next most affected by TSC. Dr. Bissler is one of only two nephrologists worldwide
with expertise in managing TSC-related kidney disease. His research has focused on alternative dialysis
means, the treatment of renal angiomyolipomas, and on the recombinogenic sequences in the PKD1 and
TSC2 genes. His research grants have come from the NIH as well as from the LAM Foundation and from
the Tuberous Sclerosis Alliance. Dr. Bissler has had 11 U.S. patents and ten foreign country patents
licensed.
He is a member of the Scientific Advisory Board for grant review of the LAM Foundation and of the
Tuberous Sclerosis Alliance. He is a member of the Editorial Board of Pediatric Nephrology and a
member of the Medical Advisory Board of the Kidney Foundation of Greater Cincinnati. Dr. Bissler is
the Director of the Pediatric Nephrology Fellowship Training Program in the Division of Nephrology and
Hypertension as well as the Associate Program Director for Research and Academic Careers.
Dr. Bissler practices at the Children's Hospital Medical Center Tuberous Sclerosis Complex Clinic in
Cincinnati, Ohio. This clinic has more than 400 patients, making it one of the largest TSC clinics in the
world. Dr. Bissler cares for the renal component of this disease process. Furthermore, in conjunction with
Dr. David Franz, Director of the Tuberous Sclerosis Clinic, and Dr. Frank McCormack, Pulmonologist
who specializes in the lymphangioleiomyomatosis, Dr. Bissler is conducting a clinical trial in hopes to
discover a pharmacological treatment for the renal lesions of TSC.